Allogene Therapeutics Inc (ALLO)
EBITDA Margin
-3287.20%
TTM · Period ending:
ALLO EBITDA Margin
Latest reported-3287.20%period ending
Latest reported-3287.20%period ending
ALLO EBITDA Margin (0.00% → -3287.20%)
Annual ebitda margin
High-resolution chart · PNG
ALLO ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0% | |
| -1,106,031.8182% | |
| -329,543.1579% | |
| -209,050.641% | |
| -150.4063% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |